ACADIA Pharmaceuticals Financial Overview
ACADIA Pharmaceuticals's market cap is currently $4.59B. The company's EPS TTM is $0.42; its P/E ratio is 17.47; ACADIA Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $0.14. See an overview of income statement, balance sheet, and cash flow financials.
